nodes	percent_of_prediction	percent_of_DWPC	metapath
Efavirenz—CYP2B6—malignant glioma	0.612	1	CbGaD
Efavirenz—CYP1A2—Carmustine—malignant glioma	0.131	0.569	CbGbCtD
Efavirenz—CYP3A4—Temozolomide—malignant glioma	0.0993	0.43	CbGbCtD
Efavirenz—Teratogenicity—Carmustine—malignant glioma	0.005	0.0413	CcSEcCtD
Efavirenz—Paresis—Temozolomide—malignant glioma	0.00277	0.0229	CcSEcCtD
Efavirenz—Opportunistic infection—Temozolomide—malignant glioma	0.00251	0.0207	CcSEcCtD
Efavirenz—Paranoid reaction—Carmustine—malignant glioma	0.00246	0.0203	CcSEcCtD
Efavirenz—Skin hyperpigmentation—Carmustine—malignant glioma	0.00176	0.0145	CcSEcCtD
Efavirenz—Cerebration impaired—Temozolomide—malignant glioma	0.00172	0.0142	CcSEcCtD
Efavirenz—Parosmia—Temozolomide—malignant glioma	0.00156	0.0129	CcSEcCtD
Efavirenz—Paranoia—Carmustine—malignant glioma	0.00154	0.0127	CcSEcCtD
Efavirenz—Myopathy—Temozolomide—malignant glioma	0.00144	0.0119	CcSEcCtD
Efavirenz—Influenza-like symptoms—Temozolomide—malignant glioma	0.00142	0.0117	CcSEcCtD
Efavirenz—Apathy—Temozolomide—malignant glioma	0.00142	0.0117	CcSEcCtD
Efavirenz—Flat affect—Temozolomide—malignant glioma	0.0014	0.0116	CcSEcCtD
Efavirenz—Stupor—Carmustine—malignant glioma	0.0014	0.0116	CcSEcCtD
Efavirenz—Hepatotoxicity—Carmustine—malignant glioma	0.00136	0.0112	CcSEcCtD
Efavirenz—Necrosis—Carmustine—malignant glioma	0.00133	0.011	CcSEcCtD
Efavirenz—Hepatotoxicity—Temozolomide—malignant glioma	0.00131	0.0108	CcSEcCtD
Efavirenz—Endocrine disorder—Temozolomide—malignant glioma	0.00122	0.0101	CcSEcCtD
Efavirenz—Speech disorder—Carmustine—malignant glioma	0.00122	0.0101	CcSEcCtD
Efavirenz—Speech disorder—Temozolomide—malignant glioma	0.00118	0.00971	CcSEcCtD
Efavirenz—Disturbance in attention—Temozolomide—malignant glioma	0.00117	0.00965	CcSEcCtD
Efavirenz—Thinking abnormal—Carmustine—malignant glioma	0.00114	0.00944	CcSEcCtD
Efavirenz—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00107	0.00883	CcSEcCtD
Efavirenz—Coordination abnormal—Carmustine—malignant glioma	0.00107	0.0088	CcSEcCtD
Efavirenz—Coordination abnormal—Temozolomide—malignant glioma	0.00103	0.00851	CcSEcCtD
Efavirenz—Depressed level of consciousness—Carmustine—malignant glioma	0.00101	0.00835	CcSEcCtD
Efavirenz—Skin exfoliation—Carmustine—malignant glioma	0.001	0.00825	CcSEcCtD
Efavirenz—Neuropathy—Carmustine—malignant glioma	0.000983	0.00812	CcSEcCtD
Efavirenz—Influenza like illness—Temozolomide—malignant glioma	0.000983	0.00811	CcSEcCtD
Efavirenz—Depressed level of consciousness—Temozolomide—malignant glioma	0.000977	0.00807	CcSEcCtD
Efavirenz—Skin exfoliation—Temozolomide—malignant glioma	0.000966	0.00798	CcSEcCtD
Efavirenz—Neuropathy—Temozolomide—malignant glioma	0.00095	0.00784	CcSEcCtD
Efavirenz—Gynaecomastia—Carmustine—malignant glioma	0.000937	0.00774	CcSEcCtD
Efavirenz—Abnormal vision—Carmustine—malignant glioma	0.000913	0.00754	CcSEcCtD
Efavirenz—Mental disability—Carmustine—malignant glioma	0.000909	0.0075	CcSEcCtD
Efavirenz—Abnormal vision—Temozolomide—malignant glioma	0.000883	0.00729	CcSEcCtD
Efavirenz—Mental disability—Temozolomide—malignant glioma	0.000878	0.00725	CcSEcCtD
Efavirenz—Thrombophlebitis—Carmustine—malignant glioma	0.000878	0.00725	CcSEcCtD
Efavirenz—Thrombophlebitis—Temozolomide—malignant glioma	0.000849	0.00701	CcSEcCtD
Efavirenz—Hepatic failure—Temozolomide—malignant glioma	0.000818	0.00675	CcSEcCtD
Efavirenz—Amnesia—Carmustine—malignant glioma	0.000809	0.00668	CcSEcCtD
Efavirenz—Hot flush—Temozolomide—malignant glioma	0.000785	0.00648	CcSEcCtD
Efavirenz—Amnesia—Temozolomide—malignant glioma	0.000782	0.00646	CcSEcCtD
Efavirenz—Menopausal symptoms—Temozolomide—malignant glioma	0.000779	0.00643	CcSEcCtD
Efavirenz—Dermatitis exfoliative—Temozolomide—malignant glioma	0.000779	0.00643	CcSEcCtD
Efavirenz—Diplopia—Carmustine—malignant glioma	0.00076	0.00628	CcSEcCtD
Efavirenz—Diplopia—Temozolomide—malignant glioma	0.000735	0.00607	CcSEcCtD
Efavirenz—Affect lability—Temozolomide—malignant glioma	0.000723	0.00597	CcSEcCtD
Efavirenz—Ataxia—Carmustine—malignant glioma	0.000715	0.0059	CcSEcCtD
Efavirenz—Mood swings—Temozolomide—malignant glioma	0.000696	0.00575	CcSEcCtD
Efavirenz—Hypokalaemia—Carmustine—malignant glioma	0.000692	0.00571	CcSEcCtD
Efavirenz—Ataxia—Temozolomide—malignant glioma	0.000691	0.0057	CcSEcCtD
Efavirenz—Muscular weakness—Carmustine—malignant glioma	0.000671	0.00554	CcSEcCtD
Efavirenz—Hypokalaemia—Temozolomide—malignant glioma	0.000669	0.00552	CcSEcCtD
Efavirenz—Breast disorder—Temozolomide—malignant glioma	0.000664	0.00548	CcSEcCtD
Efavirenz—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.000662	0.00546	CcSEcCtD
Efavirenz—Muscular weakness—Temozolomide—malignant glioma	0.000648	0.00535	CcSEcCtD
Efavirenz—Abdominal distension—Temozolomide—malignant glioma	0.000639	0.00528	CcSEcCtD
Efavirenz—Pancytopenia—Carmustine—malignant glioma	0.000624	0.00515	CcSEcCtD
Efavirenz—Sweating increased—Temozolomide—malignant glioma	0.000619	0.00511	CcSEcCtD
Efavirenz—Pancytopenia—Temozolomide—malignant glioma	0.000603	0.00498	CcSEcCtD
Efavirenz—Hyperglycaemia—Carmustine—malignant glioma	0.000593	0.00489	CcSEcCtD
Efavirenz—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00059	0.00487	CcSEcCtD
Efavirenz—Pneumonia—Carmustine—malignant glioma	0.000589	0.00486	CcSEcCtD
Efavirenz—Depression—Carmustine—malignant glioma	0.000584	0.00482	CcSEcCtD
Efavirenz—Photosensitivity reaction—Temozolomide—malignant glioma	0.00058	0.00479	CcSEcCtD
Efavirenz—Renal failure—Carmustine—malignant glioma	0.000576	0.00475	CcSEcCtD
Efavirenz—Neuropathy peripheral—Carmustine—malignant glioma	0.000574	0.00474	CcSEcCtD
Efavirenz—Hyperglycaemia—Temozolomide—malignant glioma	0.000573	0.00473	CcSEcCtD
Efavirenz—Pneumonia—Temozolomide—malignant glioma	0.000569	0.0047	CcSEcCtD
Efavirenz—Infestation—Temozolomide—malignant glioma	0.000566	0.00467	CcSEcCtD
Efavirenz—Infestation NOS—Temozolomide—malignant glioma	0.000566	0.00467	CcSEcCtD
Efavirenz—Depression—Temozolomide—malignant glioma	0.000565	0.00466	CcSEcCtD
Efavirenz—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000561	0.00463	CcSEcCtD
Efavirenz—Neuropathy peripheral—Temozolomide—malignant glioma	0.000555	0.00458	CcSEcCtD
Efavirenz—Hepatobiliary disease—Temozolomide—malignant glioma	0.000535	0.00442	CcSEcCtD
Efavirenz—Sinusitis—Temozolomide—malignant glioma	0.000531	0.00439	CcSEcCtD
Efavirenz—Hypoaesthesia—Carmustine—malignant glioma	0.000523	0.00432	CcSEcCtD
Efavirenz—Hallucination—Carmustine—malignant glioma	0.000523	0.00432	CcSEcCtD
Efavirenz—Oedema peripheral—Carmustine—malignant glioma	0.000518	0.00428	CcSEcCtD
Efavirenz—Connective tissue disorder—Carmustine—malignant glioma	0.000517	0.00427	CcSEcCtD
Efavirenz—Hepatitis—Temozolomide—malignant glioma	0.000508	0.0042	CcSEcCtD
Efavirenz—Visual impairment—Carmustine—malignant glioma	0.000507	0.00418	CcSEcCtD
Efavirenz—Hypoaesthesia—Temozolomide—malignant glioma	0.000506	0.00417	CcSEcCtD
Efavirenz—Hallucination—Temozolomide—malignant glioma	0.000506	0.00417	CcSEcCtD
Efavirenz—Urinary tract disorder—Temozolomide—malignant glioma	0.000502	0.00414	CcSEcCtD
Efavirenz—Oedema peripheral—Temozolomide—malignant glioma	0.000501	0.00413	CcSEcCtD
Efavirenz—Connective tissue disorder—Temozolomide—malignant glioma	0.000499	0.00412	CcSEcCtD
Efavirenz—Urethral disorder—Temozolomide—malignant glioma	0.000498	0.00411	CcSEcCtD
Efavirenz—Eye disorder—Carmustine—malignant glioma	0.000492	0.00406	CcSEcCtD
Efavirenz—Visual impairment—Temozolomide—malignant glioma	0.00049	0.00404	CcSEcCtD
Efavirenz—Flushing—Carmustine—malignant glioma	0.000488	0.00403	CcSEcCtD
Efavirenz—Erythema multiforme—Temozolomide—malignant glioma	0.000481	0.00397	CcSEcCtD
Efavirenz—Eye disorder—Temozolomide—malignant glioma	0.000475	0.00392	CcSEcCtD
Efavirenz—Tinnitus—Temozolomide—malignant glioma	0.000474	0.00391	CcSEcCtD
Efavirenz—Flushing—Temozolomide—malignant glioma	0.000472	0.00389	CcSEcCtD
Efavirenz—Cardiac disorder—Temozolomide—malignant glioma	0.000472	0.00389	CcSEcCtD
Efavirenz—Arrhythmia—Carmustine—malignant glioma	0.00047	0.00388	CcSEcCtD
Efavirenz—Alopecia—Carmustine—malignant glioma	0.000465	0.00384	CcSEcCtD
Efavirenz—Angiopathy—Temozolomide—malignant glioma	0.000461	0.00381	CcSEcCtD
Efavirenz—Immune system disorder—Temozolomide—malignant glioma	0.000459	0.00379	CcSEcCtD
Efavirenz—Mediastinal disorder—Temozolomide—malignant glioma	0.000458	0.00378	CcSEcCtD
Efavirenz—Erythema—Carmustine—malignant glioma	0.000458	0.00378	CcSEcCtD
Efavirenz—Malnutrition—Carmustine—malignant glioma	0.000458	0.00378	CcSEcCtD
Efavirenz—Alopecia—Temozolomide—malignant glioma	0.000449	0.00371	CcSEcCtD
Efavirenz—Back pain—Carmustine—malignant glioma	0.000443	0.00366	CcSEcCtD
Efavirenz—Malnutrition—Temozolomide—malignant glioma	0.000442	0.00365	CcSEcCtD
Efavirenz—Erythema—Temozolomide—malignant glioma	0.000442	0.00365	CcSEcCtD
Efavirenz—Dysgeusia—Temozolomide—malignant glioma	0.000433	0.00358	CcSEcCtD
Efavirenz—Vision blurred—Carmustine—malignant glioma	0.000431	0.00356	CcSEcCtD
Efavirenz—Tremor—Carmustine—malignant glioma	0.000429	0.00354	CcSEcCtD
Efavirenz—Back pain—Temozolomide—malignant glioma	0.000428	0.00353	CcSEcCtD
Efavirenz—Anaemia—Carmustine—malignant glioma	0.000423	0.00349	CcSEcCtD
Efavirenz—Agitation—Carmustine—malignant glioma	0.000421	0.00347	CcSEcCtD
Efavirenz—Vision blurred—Temozolomide—malignant glioma	0.000417	0.00344	CcSEcCtD
Efavirenz—Tremor—Temozolomide—malignant glioma	0.000415	0.00342	CcSEcCtD
Efavirenz—Ill-defined disorder—Temozolomide—malignant glioma	0.000411	0.00339	CcSEcCtD
Efavirenz—Anaemia—Temozolomide—malignant glioma	0.000409	0.00338	CcSEcCtD
Efavirenz—Agitation—Temozolomide—malignant glioma	0.000407	0.00336	CcSEcCtD
Efavirenz—Angioedema—Temozolomide—malignant glioma	0.000404	0.00334	CcSEcCtD
Efavirenz—Malaise—Temozolomide—malignant glioma	0.000399	0.00329	CcSEcCtD
Efavirenz—Vertigo—Temozolomide—malignant glioma	0.000398	0.00328	CcSEcCtD
Efavirenz—Convulsion—Carmustine—malignant glioma	0.000397	0.00327	CcSEcCtD
Efavirenz—Hypertension—Carmustine—malignant glioma	0.000395	0.00326	CcSEcCtD
Efavirenz—Palpitations—Temozolomide—malignant glioma	0.000391	0.00323	CcSEcCtD
Efavirenz—Chest pain—Carmustine—malignant glioma	0.00039	0.00322	CcSEcCtD
Efavirenz—Myalgia—Carmustine—malignant glioma	0.00039	0.00322	CcSEcCtD
Efavirenz—Anxiety—Carmustine—malignant glioma	0.000388	0.00321	CcSEcCtD
Efavirenz—Cough—Temozolomide—malignant glioma	0.000386	0.00319	CcSEcCtD
Efavirenz—Convulsion—Temozolomide—malignant glioma	0.000383	0.00316	CcSEcCtD
Efavirenz—Hypertension—Temozolomide—malignant glioma	0.000382	0.00315	CcSEcCtD
Efavirenz—Confusional state—Carmustine—malignant glioma	0.000377	0.00311	CcSEcCtD
Efavirenz—Arthralgia—Temozolomide—malignant glioma	0.000377	0.00311	CcSEcCtD
Efavirenz—Myalgia—Temozolomide—malignant glioma	0.000377	0.00311	CcSEcCtD
Efavirenz—Anxiety—Temozolomide—malignant glioma	0.000375	0.0031	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000374	0.00309	CcSEcCtD
Efavirenz—Discomfort—Temozolomide—malignant glioma	0.000372	0.00307	CcSEcCtD
Efavirenz—Dry mouth—Temozolomide—malignant glioma	0.000368	0.00304	CcSEcCtD
Efavirenz—Thrombocytopenia—Carmustine—malignant glioma	0.000366	0.00302	CcSEcCtD
Efavirenz—Tachycardia—Carmustine—malignant glioma	0.000365	0.00301	CcSEcCtD
Efavirenz—Confusional state—Temozolomide—malignant glioma	0.000364	0.00301	CcSEcCtD
Efavirenz—Anorexia—Carmustine—malignant glioma	0.000356	0.00294	CcSEcCtD
Efavirenz—Nervous system disorder—Temozolomide—malignant glioma	0.000354	0.00292	CcSEcCtD
Efavirenz—Thrombocytopenia—Temozolomide—malignant glioma	0.000354	0.00292	CcSEcCtD
Efavirenz—Skin disorder—Temozolomide—malignant glioma	0.000351	0.0029	CcSEcCtD
Efavirenz—Hyperhidrosis—Temozolomide—malignant glioma	0.000349	0.00288	CcSEcCtD
Efavirenz—Anorexia—Temozolomide—malignant glioma	0.000344	0.00284	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00034	0.00281	CcSEcCtD
Efavirenz—Insomnia—Carmustine—malignant glioma	0.000338	0.00279	CcSEcCtD
Efavirenz—Paraesthesia—Carmustine—malignant glioma	0.000336	0.00277	CcSEcCtD
Efavirenz—Dyspnoea—Carmustine—malignant glioma	0.000333	0.00275	CcSEcCtD
Efavirenz—Somnolence—Carmustine—malignant glioma	0.000332	0.00274	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000329	0.00272	CcSEcCtD
Efavirenz—Insomnia—Temozolomide—malignant glioma	0.000327	0.0027	CcSEcCtD
Efavirenz—Decreased appetite—Carmustine—malignant glioma	0.000325	0.00268	CcSEcCtD
Efavirenz—Paraesthesia—Temozolomide—malignant glioma	0.000324	0.00268	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Carmustine—malignant glioma	0.000323	0.00266	CcSEcCtD
Efavirenz—Dyspnoea—Temozolomide—malignant glioma	0.000322	0.00266	CcSEcCtD
Efavirenz—Somnolence—Temozolomide—malignant glioma	0.000321	0.00265	CcSEcCtD
Efavirenz—Pain—Carmustine—malignant glioma	0.00032	0.00264	CcSEcCtD
Efavirenz—Constipation—Carmustine—malignant glioma	0.00032	0.00264	CcSEcCtD
Efavirenz—Dyspepsia—Temozolomide—malignant glioma	0.000318	0.00262	CcSEcCtD
Efavirenz—Decreased appetite—Temozolomide—malignant glioma	0.000314	0.00259	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000312	0.00257	CcSEcCtD
Efavirenz—Fatigue—Temozolomide—malignant glioma	0.000311	0.00257	CcSEcCtD
Efavirenz—Constipation—Temozolomide—malignant glioma	0.000309	0.00255	CcSEcCtD
Efavirenz—Pain—Temozolomide—malignant glioma	0.000309	0.00255	CcSEcCtD
Efavirenz—Feeling abnormal—Carmustine—malignant glioma	0.000308	0.00254	CcSEcCtD
Efavirenz—Gastrointestinal pain—Carmustine—malignant glioma	0.000306	0.00252	CcSEcCtD
Efavirenz—Feeling abnormal—Temozolomide—malignant glioma	0.000298	0.00246	CcSEcCtD
Efavirenz—Body temperature increased—Carmustine—malignant glioma	0.000295	0.00244	CcSEcCtD
Efavirenz—Abdominal pain—Carmustine—malignant glioma	0.000295	0.00244	CcSEcCtD
Efavirenz—Gastrointestinal pain—Temozolomide—malignant glioma	0.000295	0.00244	CcSEcCtD
Efavirenz—Urticaria—Temozolomide—malignant glioma	0.000287	0.00237	CcSEcCtD
Efavirenz—Abdominal pain—Temozolomide—malignant glioma	0.000285	0.00236	CcSEcCtD
Efavirenz—Body temperature increased—Temozolomide—malignant glioma	0.000285	0.00236	CcSEcCtD
Efavirenz—Hypersensitivity—Carmustine—malignant glioma	0.000275	0.00227	CcSEcCtD
Efavirenz—Asthenia—Carmustine—malignant glioma	0.000268	0.00221	CcSEcCtD
Efavirenz—Hypersensitivity—Temozolomide—malignant glioma	0.000266	0.0022	CcSEcCtD
Efavirenz—Asthenia—Temozolomide—malignant glioma	0.000259	0.00214	CcSEcCtD
Efavirenz—Diarrhoea—Carmustine—malignant glioma	0.000256	0.00211	CcSEcCtD
Efavirenz—Pruritus—Temozolomide—malignant glioma	0.000255	0.00211	CcSEcCtD
Efavirenz—Dizziness—Carmustine—malignant glioma	0.000247	0.00204	CcSEcCtD
Efavirenz—Diarrhoea—Temozolomide—malignant glioma	0.000247	0.00204	CcSEcCtD
Efavirenz—Dizziness—Temozolomide—malignant glioma	0.000239	0.00197	CcSEcCtD
Efavirenz—Vomiting—Carmustine—malignant glioma	0.000238	0.00196	CcSEcCtD
Efavirenz—Rash—Carmustine—malignant glioma	0.000236	0.00195	CcSEcCtD
Efavirenz—Dermatitis—Carmustine—malignant glioma	0.000235	0.00194	CcSEcCtD
Efavirenz—Headache—Carmustine—malignant glioma	0.000234	0.00193	CcSEcCtD
Efavirenz—Vomiting—Temozolomide—malignant glioma	0.00023	0.0019	CcSEcCtD
Efavirenz—Rash—Temozolomide—malignant glioma	0.000228	0.00188	CcSEcCtD
Efavirenz—Dermatitis—Temozolomide—malignant glioma	0.000227	0.00188	CcSEcCtD
Efavirenz—Headache—Temozolomide—malignant glioma	0.000226	0.00187	CcSEcCtD
Efavirenz—Nausea—Carmustine—malignant glioma	0.000222	0.00183	CcSEcCtD
Efavirenz—Nausea—Temozolomide—malignant glioma	0.000214	0.00177	CcSEcCtD
Efavirenz—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	8.56e-05	0.00234	CbGpPWpGaD
Efavirenz—CYP2C9—Biological oxidations—CYP2B6—malignant glioma	8.56e-05	0.00234	CbGpPWpGaD
Efavirenz—CYP2D6—Metapathway biotransformation—CYP2B6—malignant glioma	8.51e-05	0.00233	CbGpPWpGaD
Efavirenz—CYP2C9—Metapathway biotransformation—CYP2B6—malignant glioma	8.44e-05	0.00231	CbGpPWpGaD
Efavirenz—CYP2B6—Biological oxidations—PTGS1—malignant glioma	8.16e-05	0.00223	CbGpPWpGaD
Efavirenz—CYP2C19—Biological oxidations—CYP2C18—malignant glioma	8.14e-05	0.00222	CbGpPWpGaD
Efavirenz—CYP2C19—Metapathway biotransformation—CYP2C18—malignant glioma	8.03e-05	0.00219	CbGpPWpGaD
Efavirenz—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	7.67e-05	0.00209	CbGpPWpGaD
Efavirenz—CYP2D6—Biological oxidations—CYP2C18—malignant glioma	7.48e-05	0.00204	CbGpPWpGaD
Efavirenz—CYP2C9—Biological oxidations—CYP2C18—malignant glioma	7.42e-05	0.00203	CbGpPWpGaD
Efavirenz—CYP2D6—Metapathway biotransformation—CYP2C18—malignant glioma	7.38e-05	0.00202	CbGpPWpGaD
Efavirenz—CYP2C9—Metapathway biotransformation—CYP2C18—malignant glioma	7.32e-05	0.002	CbGpPWpGaD
Efavirenz—CYP1A2—Biological oxidations—CYP2B6—malignant glioma	7.31e-05	0.002	CbGpPWpGaD
Efavirenz—CYP1A2—Metapathway biotransformation—CYP2B6—malignant glioma	7.21e-05	0.00197	CbGpPWpGaD
Efavirenz—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	6.98e-05	0.00191	CbGpPWpGaD
Efavirenz—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	6.61e-05	0.00181	CbGpPWpGaD
Efavirenz—CYP2C19—Biological oxidations—GSTT1—malignant glioma	6.58e-05	0.0018	CbGpPWpGaD
Efavirenz—CYP2C19—Arachidonic acid metabolism—PTGS2—malignant glioma	6.35e-05	0.00173	CbGpPWpGaD
Efavirenz—CYP1A2—Biological oxidations—CYP2C18—malignant glioma	6.34e-05	0.00173	CbGpPWpGaD
Efavirenz—CYP1A2—Metapathway biotransformation—CYP2C18—malignant glioma	6.25e-05	0.00171	CbGpPWpGaD
Efavirenz—CYP2C19—Biological oxidations—PTGS1—malignant glioma	6.17e-05	0.00168	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—RTEL1—malignant glioma	6.1e-05	0.00167	CbGpPWpGaD
Efavirenz—CYP1A2—Phase II conjugation—GSTP1—malignant glioma	6.08e-05	0.00166	CbGpPWpGaD
Efavirenz—CYP2D6—Biological oxidations—GSTT1—malignant glioma	6.05e-05	0.00165	CbGpPWpGaD
Efavirenz—CYP2B6—Biological oxidations—GSTP1—malignant glioma	6.04e-05	0.00165	CbGpPWpGaD
Efavirenz—CYP2C9—Biological oxidations—GSTT1—malignant glioma	6e-05	0.00164	CbGpPWpGaD
Efavirenz—CYP2B6—Metapathway biotransformation—GSTP1—malignant glioma	5.95e-05	0.00163	CbGpPWpGaD
Efavirenz—CYP2C9—Arachidonic acid metabolism—PTGS2—malignant glioma	5.79e-05	0.00158	CbGpPWpGaD
Efavirenz—CYP2D6—Biological oxidations—PTGS1—malignant glioma	5.67e-05	0.00155	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	5.64e-05	0.00154	CbGpPWpGaD
Efavirenz—CYP2C9—Biological oxidations—PTGS1—malignant glioma	5.62e-05	0.00154	CbGpPWpGaD
Efavirenz—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	5.57e-05	0.00152	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—malignant glioma	5.52e-05	0.00151	CbGpPWpGaD
Efavirenz—CYP1A2—Tryptophan metabolism—MDM2—malignant glioma	5.49e-05	0.0015	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—malignant glioma	5.47e-05	0.00149	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—malignant glioma	5.29e-05	0.00145	CbGpPWpGaD
Efavirenz—CYP1A2—Biological oxidations—GSTT1—malignant glioma	5.13e-05	0.0014	CbGpPWpGaD
Efavirenz—CYP1A2—Arachidonic acid metabolism—PTGS2—malignant glioma	4.95e-05	0.00135	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—malignant glioma	4.92e-05	0.00134	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—malignant glioma	4.9e-05	0.00134	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	4.89e-05	0.00134	CbGpPWpGaD
Efavirenz—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	4.83e-05	0.00132	CbGpPWpGaD
Efavirenz—CYP1A2—Biological oxidations—PTGS1—malignant glioma	4.81e-05	0.00131	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—RTEL1—malignant glioma	4.61e-05	0.00126	CbGpPWpGaD
Efavirenz—CYP2C19—Biological oxidations—GSTP1—malignant glioma	4.56e-05	0.00125	CbGpPWpGaD
Efavirenz—CYP2C19—Metapathway biotransformation—GSTP1—malignant glioma	4.5e-05	0.00123	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—RTEL1—malignant glioma	4.24e-05	0.00116	CbGpPWpGaD
Efavirenz—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	4.23e-05	0.00116	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—RTEL1—malignant glioma	4.21e-05	0.00115	CbGpPWpGaD
Efavirenz—CYP2D6—Biological oxidations—GSTP1—malignant glioma	4.2e-05	0.00115	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	4.17e-05	0.00114	CbGpPWpGaD
Efavirenz—CYP2C9—Biological oxidations—GSTP1—malignant glioma	4.16e-05	0.00114	CbGpPWpGaD
Efavirenz—CYP2D6—Metapathway biotransformation—GSTP1—malignant glioma	4.14e-05	0.00113	CbGpPWpGaD
Efavirenz—CYP2C9—Metapathway biotransformation—GSTP1—malignant glioma	4.1e-05	0.00112	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—GSTT1—malignant glioma	3.96e-05	0.00108	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor—MYC—malignant glioma	3.83e-05	0.00105	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	3.75e-05	0.00102	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	3.75e-05	0.00102	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—PTGS1—malignant glioma	3.71e-05	0.00101	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—RTEL1—malignant glioma	3.59e-05	0.000982	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	3.57e-05	0.000976	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	3.57e-05	0.000976	CbGpPWpGaD
Efavirenz—CYP1A2—Biological oxidations—GSTP1—malignant glioma	3.55e-05	0.000971	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	3.54e-05	0.000968	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—COX8A—malignant glioma	3.51e-05	0.000958	CbGpPWpGaD
Efavirenz—CYP1A2—Metapathway biotransformation—GSTP1—malignant glioma	3.51e-05	0.000958	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	3.3e-05	0.000901	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	3.19e-05	0.000871	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	3.01e-05	0.000821	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ASMT—malignant glioma	2.98e-05	0.000814	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	2.91e-05	0.000795	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—BCAN—malignant glioma	2.8e-05	0.000766	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—RTEL1—malignant glioma	2.77e-05	0.000758	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—GSTP1—malignant glioma	2.74e-05	0.00075	CbGpPWpGaD
Efavirenz—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	2.71e-05	0.000739	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—COX8A—malignant glioma	2.65e-05	0.000724	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	2.57e-05	0.000702	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	2.49e-05	0.000679	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—COX8A—malignant glioma	2.44e-05	0.000666	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—COX8A—malignant glioma	2.42e-05	0.00066	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	2.37e-05	0.000647	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—IDH2—malignant glioma	2.26e-05	0.000617	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ASMT—malignant glioma	2.25e-05	0.000615	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	2.2e-05	0.000602	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	2.16e-05	0.00059	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—BCAN—malignant glioma	2.12e-05	0.000579	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ASMT—malignant glioma	2.07e-05	0.000566	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—COX8A—malignant glioma	2.06e-05	0.000564	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ASMT—malignant glioma	2.05e-05	0.000561	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	2.01e-05	0.000548	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—BCAN—malignant glioma	1.95e-05	0.000532	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—IDH1—malignant glioma	1.94e-05	0.000531	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—BCAN—malignant glioma	1.93e-05	0.000528	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—SPHK1—malignant glioma	1.88e-05	0.000514	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	1.85e-05	0.000504	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CYP2C18—malignant glioma	1.84e-05	0.000503	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ASMT—malignant glioma	1.76e-05	0.00048	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	1.72e-05	0.000469	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—IDH2—malignant glioma	1.71e-05	0.000466	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—BCAN—malignant glioma	1.65e-05	0.000451	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.61e-05	0.00044	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CYP2B6—malignant glioma	1.6e-05	0.000439	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—COX8A—malignant glioma	1.59e-05	0.000435	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—IDH2—malignant glioma	1.57e-05	0.000429	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—IDH2—malignant glioma	1.56e-05	0.000425	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GSTT1—malignant glioma	1.49e-05	0.000407	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CYP2B6—malignant glioma	1.48e-05	0.000403	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—IDH1—malignant glioma	1.47e-05	0.000401	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.47e-05	0.000401	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CYP2B6—malignant glioma	1.46e-05	0.0004	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—SPHK1—malignant glioma	1.42e-05	0.000388	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PTGS1—malignant glioma	1.4e-05	0.000381	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CYP2C18—malignant glioma	1.39e-05	0.00038	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ASMT—malignant glioma	1.35e-05	0.00037	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—IDH1—malignant glioma	1.35e-05	0.000369	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—IDH1—malignant glioma	1.34e-05	0.000366	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—IDH2—malignant glioma	1.33e-05	0.000363	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.31e-05	0.000359	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—SPHK1—malignant glioma	1.31e-05	0.000357	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—BCHE—malignant glioma	1.3e-05	0.000355	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—SPHK1—malignant glioma	1.3e-05	0.000354	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—SLC5A5—malignant glioma	1.28e-05	0.00035	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CYP2C18—malignant glioma	1.28e-05	0.00035	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—BCAN—malignant glioma	1.27e-05	0.000348	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CYP2C18—malignant glioma	1.27e-05	0.000347	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.25e-05	0.000343	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP2B6—malignant glioma	1.25e-05	0.000342	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.2e-05	0.000327	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.2e-05	0.000327	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.15e-05	0.000315	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—IDH1—malignant glioma	1.14e-05	0.000313	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GSTT1—malignant glioma	1.13e-05	0.000308	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—SPHK1—malignant glioma	1.11e-05	0.000302	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.09e-05	0.000298	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP2C18—malignant glioma	1.08e-05	0.000296	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PTGS1—malignant glioma	1.05e-05	0.000288	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.05e-05	0.000287	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.05e-05	0.000287	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GSTT1—malignant glioma	1.04e-05	0.000283	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GSTP1—malignant glioma	1.03e-05	0.000282	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—IDH2—malignant glioma	1.03e-05	0.00028	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GSTT1—malignant glioma	1.03e-05	0.00028	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.02e-05	0.000279	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CAT—malignant glioma	1e-05	0.000274	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—BCHE—malignant glioma	9.8e-06	0.000268	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PTGS1—malignant glioma	9.7e-06	0.000265	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—SLC5A5—malignant glioma	9.68e-06	0.000265	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP2B6—malignant glioma	9.65e-06	0.000264	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PTGS1—malignant glioma	9.62e-06	0.000263	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	9.58e-06	0.000262	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—NCOR1—malignant glioma	9.49e-06	0.000259	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	9.31e-06	0.000254	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	9.16e-06	0.00025	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	9.07e-06	0.000248	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—BCHE—malignant glioma	9.02e-06	0.000246	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	8.99e-06	0.000246	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—BCHE—malignant glioma	8.94e-06	0.000244	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—SLC5A5—malignant glioma	8.91e-06	0.000243	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—SLC5A5—malignant glioma	8.83e-06	0.000241	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—IDH1—malignant glioma	8.83e-06	0.000241	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GSTT1—malignant glioma	8.77e-06	0.00024	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—SPHK1—malignant glioma	8.54e-06	0.000233	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP2C18—malignant glioma	8.37e-06	0.000229	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	8.35e-06	0.000228	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	8.27e-06	0.000226	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PTGS1—malignant glioma	8.22e-06	0.000225	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	8.19e-06	0.000224	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	7.91e-06	0.000216	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GSTP1—malignant glioma	7.8e-06	0.000213	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CAV1—malignant glioma	7.73e-06	0.000211	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—BCHE—malignant glioma	7.64e-06	0.000209	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CAT—malignant glioma	7.59e-06	0.000207	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—SLC5A5—malignant glioma	7.55e-06	0.000206	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	7.22e-06	0.000197	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GSTP1—malignant glioma	7.18e-06	0.000196	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—NCOR1—malignant glioma	7.17e-06	0.000196	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	7.14e-06	0.000195	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GSTP1—malignant glioma	7.11e-06	0.000194	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	7.07e-06	0.000193	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PIK3CG—malignant glioma	7.04e-06	0.000192	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CAT—malignant glioma	6.98e-06	0.000191	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CAT—malignant glioma	6.92e-06	0.000189	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PPARG—malignant glioma	6.8e-06	0.000186	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTT1—malignant glioma	6.77e-06	0.000185	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—NCOR1—malignant glioma	6.59e-06	0.00018	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—NCOR1—malignant glioma	6.54e-06	0.000179	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PTGS1—malignant glioma	6.34e-06	0.000173	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PIK3CD—malignant glioma	6.19e-06	0.000169	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	6.17e-06	0.000168	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GSTP1—malignant glioma	6.08e-06	0.000166	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CAT—malignant glioma	5.91e-06	0.000162	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—BCHE—malignant glioma	5.9e-06	0.000161	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CAV1—malignant glioma	5.84e-06	0.00016	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—SLC5A5—malignant glioma	5.82e-06	0.000159	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—NCOR1—malignant glioma	5.59e-06	0.000153	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.58e-06	0.000153	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PIK3CB—malignant glioma	5.4e-06	0.000147	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CAV1—malignant glioma	5.38e-06	0.000147	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PTGS2—malignant glioma	5.35e-06	0.000146	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CAV1—malignant glioma	5.33e-06	0.000146	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PIK3CG—malignant glioma	5.32e-06	0.000145	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PPARG—malignant glioma	5.14e-06	0.00014	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.09e-06	0.000139	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PIK3CG—malignant glioma	4.9e-06	0.000134	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PIK3CG—malignant glioma	4.85e-06	0.000133	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PPARG—malignant glioma	4.73e-06	0.000129	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTP1—malignant glioma	4.69e-06	0.000128	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PPARG—malignant glioma	4.68e-06	0.000128	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PIK3CD—malignant glioma	4.68e-06	0.000128	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PTEN—malignant glioma	4.66e-06	0.000127	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CAT—malignant glioma	4.56e-06	0.000125	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CAV1—malignant glioma	4.55e-06	0.000124	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.35e-06	0.000119	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—NCOR1—malignant glioma	4.31e-06	0.000118	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PIK3CD—malignant glioma	4.3e-06	0.000118	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PIK3CD—malignant glioma	4.27e-06	0.000117	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PIK3CG—malignant glioma	4.15e-06	0.000113	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PIK3CB—malignant glioma	4.08e-06	0.000111	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PTGS2—malignant glioma	4.04e-06	0.00011	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PPARG—malignant glioma	4e-06	0.000109	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PIK3CB—malignant glioma	3.75e-06	0.000103	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PIK3CB—malignant glioma	3.72e-06	0.000102	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PTGS2—malignant glioma	3.72e-06	0.000102	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PTGS2—malignant glioma	3.69e-06	0.000101	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PIK3CD—malignant glioma	3.65e-06	9.96e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PTEN—malignant glioma	3.52e-06	9.63e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CAV1—malignant glioma	3.51e-06	9.6e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PIK3CA—malignant glioma	3.29e-06	8.99e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PTEN—malignant glioma	3.24e-06	8.86e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PTEN—malignant glioma	3.21e-06	8.78e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PIK3CG—malignant glioma	3.2e-06	8.75e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PIK3CB—malignant glioma	3.18e-06	8.68e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PTGS2—malignant glioma	3.15e-06	8.6e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PPARG—malignant glioma	3.09e-06	8.44e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PIK3CD—malignant glioma	2.81e-06	7.69e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PTEN—malignant glioma	2.75e-06	7.5e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—AKT1—malignant glioma	2.69e-06	7.34e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PIK3CA—malignant glioma	2.49e-06	6.79e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.45e-06	6.7e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PTGS2—malignant glioma	2.43e-06	6.64e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PIK3CA—malignant glioma	2.29e-06	6.25e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PIK3CA—malignant glioma	2.27e-06	6.19e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PTEN—malignant glioma	2.12e-06	5.79e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—AKT1—malignant glioma	2.03e-06	5.55e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PIK3CA—malignant glioma	1.94e-06	5.29e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—AKT1—malignant glioma	1.87e-06	5.1e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—AKT1—malignant glioma	1.85e-06	5.06e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—AKT1—malignant glioma	1.58e-06	4.32e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.5e-06	4.09e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—AKT1—malignant glioma	1.22e-06	3.34e-05	CbGpPWpGaD
